| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of synapse-associated extracellular matrix | 1.49e-05 | 3 | 45 | 2 | GO:0150043 | |
| GeneOntologyMolecularFunction | chondroitin sulfate binding | 2.70e-04 | 11 | 45 | 2 | GO:0035374 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 3.31e-04 | 268 | 45 | 5 | GO:0005539 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 5.96e-04 | 73 | 45 | 3 | GO:0050840 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 7.72e-04 | 323 | 45 | 5 | GO:1901681 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 9.28e-04 | 85 | 45 | 3 | GO:0038024 | |
| GeneOntologyMolecularFunction | semaphorin receptor binding | 1.22e-03 | 23 | 45 | 2 | GO:0030215 | |
| GeneOntologyMolecularFunction | Notch binding | 1.68e-03 | 27 | 45 | 2 | GO:0005112 | |
| GeneOntologyBiologicalProcess | positive regulation of vascular endothelial growth factor signaling pathway | 8.08e-07 | 9 | 45 | 3 | GO:1900748 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | LAMB1 LAMB2 PELI1 SMOC2 PHF10 TNXB WNT1 RCC2 MEGF10 PLXNB1 VEGFA | 3.55e-06 | 927 | 45 | 11 | GO:0030155 |
| GeneOntologyBiologicalProcess | engulfment of apoptotic cell | 4.34e-06 | 15 | 45 | 3 | GO:0043652 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 2.76e-05 | 410 | 45 | 7 | GO:0031589 | |
| GeneOntologyBiologicalProcess | regulation of vascular endothelial growth factor signaling pathway | 3.78e-05 | 30 | 45 | 3 | GO:1900746 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to vascular endothelial growth factor stimulus | 4.60e-05 | 32 | 45 | 3 | GO:1902547 | |
| GeneOntologyBiologicalProcess | negative regulation of cell adhesion | 1.55e-04 | 375 | 45 | 6 | GO:0007162 | |
| GeneOntologyBiologicalProcess | apoptotic cell clearance | 1.57e-04 | 48 | 45 | 3 | GO:0043277 | |
| GeneOntologyBiologicalProcess | vascular endothelial growth factor signaling pathway | 1.88e-04 | 51 | 45 | 3 | GO:0038084 | |
| GeneOntologyBiologicalProcess | axonogenesis | 2.07e-04 | 566 | 45 | 7 | GO:0007409 | |
| GeneOntologyBiologicalProcess | positive regulation of cell adhesion | 2.38e-04 | 579 | 45 | 7 | GO:0045785 | |
| GeneOntologyBiologicalProcess | regulation of basement membrane organization | 2.53e-04 | 11 | 45 | 2 | GO:0110011 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 2.58e-04 | 412 | 45 | 6 | GO:0090287 | |
| GeneOntologyBiologicalProcess | extracellular matrix assembly | 2.90e-04 | 59 | 45 | 3 | GO:0085029 | |
| GeneOntologyBiologicalProcess | basement membrane assembly | 3.03e-04 | 12 | 45 | 2 | GO:0070831 | |
| GeneOntologyBiologicalProcess | axon guidance | 3.78e-04 | 285 | 45 | 5 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 3.84e-04 | 286 | 45 | 5 | GO:0097485 | |
| GeneOntologyBiologicalProcess | positive regulation of integrin-mediated signaling pathway | 4.17e-04 | 14 | 45 | 2 | GO:2001046 | |
| GeneOntologyBiologicalProcess | regulation of toll-like receptor 3 signaling pathway | 4.17e-04 | 14 | 45 | 2 | GO:0034139 | |
| GeneOntologyBiologicalProcess | axon development | 4.44e-04 | 642 | 45 | 7 | GO:0061564 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | 4.51e-04 | 1077 | 45 | 9 | GO:0098609 | |
| GeneOntologyBiologicalProcess | phagocytosis, engulfment | 4.60e-04 | 69 | 45 | 3 | GO:0006911 | |
| GeneOntologyBiologicalProcess | cellular response to vascular endothelial growth factor stimulus | 6.10e-04 | 76 | 45 | 3 | GO:0035924 | |
| GeneOntologyBiologicalProcess | positive regulation of endothelial cell chemotaxis | 6.20e-04 | 17 | 45 | 2 | GO:2001028 | |
| GeneOntologyBiologicalProcess | plasma membrane invagination | 6.58e-04 | 78 | 45 | 3 | GO:0099024 | |
| GeneOntologyBiologicalProcess | regulation of extracellular matrix organization | 8.17e-04 | 84 | 45 | 3 | GO:1903053 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 6.64e-06 | 17 | 46 | 3 | GO:0098637 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 1.47e-04 | 530 | 46 | 7 | GO:0062023 | |
| GeneOntologyCellularComponent | basement membrane | 1.49e-04 | 122 | 46 | 4 | GO:0005604 | |
| GeneOntologyCellularComponent | laminin complex | 2.11e-04 | 10 | 46 | 2 | GO:0043256 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 2.97e-04 | 59 | 46 | 3 | GO:0098636 | |
| GeneOntologyCellularComponent | extracellular matrix | 5.36e-04 | 656 | 46 | 7 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 5.46e-04 | 658 | 46 | 7 | GO:0030312 | |
| GeneOntologyCellularComponent | cell surface | 6.08e-04 | 1111 | 46 | 9 | GO:0009986 | |
| GeneOntologyCellularComponent | phagocytic cup | 2.12e-03 | 31 | 46 | 2 | GO:0001891 | |
| Domain | EGF | LAMB1 LAMB2 ADAM33 ADGRE5 EGFL7 ADGRE2 MEGF6 TNXB MEGF11 MEGF10 CRB2 | 3.01e-12 | 235 | 42 | 11 | SM00181 |
| Domain | EGF-like_dom | LAMB1 LAMB2 ADAM33 ADGRE5 EGFL7 ADGRE2 MEGF6 TNXB MEGF11 MEGF10 CRB2 | 5.64e-12 | 249 | 42 | 11 | IPR000742 |
| Domain | EGF_1 | LAMB1 LAMB2 ADAM33 EGFL7 ADGRE2 MEGF6 TNXB MEGF11 MEGF10 CRB2 | 1.89e-10 | 255 | 42 | 10 | PS00022 |
| Domain | EGF-like_CS | LAMB1 LAMB2 ADAM33 EGFL7 ADGRE2 MEGF6 TNXB MEGF11 MEGF10 CRB2 | 2.37e-10 | 261 | 42 | 10 | IPR013032 |
| Domain | EGF_2 | LAMB1 LAMB2 ADAM33 EGFL7 ADGRE2 MEGF6 TNXB MEGF11 MEGF10 CRB2 | 2.75e-10 | 265 | 42 | 10 | PS01186 |
| Domain | Growth_fac_rcpt_ | 1.83e-09 | 156 | 42 | 8 | IPR009030 | |
| Domain | EGF_3 | 2.11e-09 | 235 | 42 | 9 | PS50026 | |
| Domain | EGF_extracell | 4.08e-09 | 60 | 42 | 6 | IPR013111 | |
| Domain | EGF_2 | 4.08e-09 | 60 | 42 | 6 | PF07974 | |
| Domain | Laminin_EGF | 1.39e-08 | 35 | 42 | 5 | PF00053 | |
| Domain | EGF_Lam | 1.39e-08 | 35 | 42 | 5 | SM00180 | |
| Domain | Laminin_EGF | 2.14e-08 | 38 | 42 | 5 | IPR002049 | |
| Domain | EMI_domain | 3.94e-08 | 16 | 42 | 4 | IPR011489 | |
| Domain | EMI | 5.15e-08 | 17 | 42 | 4 | PS51041 | |
| Domain | hEGF | 4.35e-07 | 28 | 42 | 4 | PF12661 | |
| Domain | EGF_Ca-bd_CS | 2.49e-06 | 97 | 42 | 5 | IPR018097 | |
| Domain | EGF_CA | 2.75e-06 | 99 | 42 | 5 | PS01187 | |
| Domain | ASX_HYDROXYL | 2.89e-06 | 100 | 42 | 5 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 3.85e-06 | 106 | 42 | 5 | IPR000152 | |
| Domain | GPCR_2_CD97 | 4.94e-06 | 2 | 42 | 2 | IPR003056 | |
| Domain | EGF_CA | 7.68e-06 | 122 | 42 | 5 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 8.31e-06 | 124 | 42 | 5 | IPR001881 | |
| Domain | LAMININ_IVB | 1.48e-05 | 3 | 42 | 2 | PS51116 | |
| Domain | Laminin_IV_B | 1.48e-05 | 3 | 42 | 2 | IPR013015 | |
| Domain | EGF_CA | 4.10e-05 | 86 | 42 | 4 | PF07645 | |
| Domain | - | 9.38e-05 | 333 | 42 | 6 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 9.69e-05 | 335 | 42 | 6 | IPR015943 | |
| Domain | LAMININ_NTER | 5.81e-04 | 16 | 42 | 2 | PS51117 | |
| Domain | Laminin_N | 5.81e-04 | 16 | 42 | 2 | PF00055 | |
| Domain | Laminin_N | 5.81e-04 | 16 | 42 | 2 | IPR008211 | |
| Domain | LamNT | 5.81e-04 | 16 | 42 | 2 | SM00136 | |
| Domain | Galactose-bd-like | 1.23e-03 | 94 | 42 | 3 | IPR008979 | |
| Domain | EGF_LAM_2 | 2.06e-03 | 30 | 42 | 2 | PS50027 | |
| Domain | EGF_LAM_1 | 2.06e-03 | 30 | 42 | 2 | PS01248 | |
| Domain | SEMA | 2.20e-03 | 31 | 42 | 2 | PS51004 | |
| Domain | Sema | 2.20e-03 | 31 | 42 | 2 | SM00630 | |
| Domain | Semap_dom | 2.20e-03 | 31 | 42 | 2 | IPR001627 | |
| Domain | Sema | 2.20e-03 | 31 | 42 | 2 | PF01403 | |
| Domain | Plexin_repeat | 2.35e-03 | 32 | 42 | 2 | IPR002165 | |
| Domain | PSI | 2.35e-03 | 32 | 42 | 2 | PF01437 | |
| Domain | GPS | 2.65e-03 | 34 | 42 | 2 | SM00303 | |
| Domain | GPCR_2_secretin-like_CS | 2.65e-03 | 34 | 42 | 2 | IPR017983 | |
| Domain | GPS | 2.80e-03 | 35 | 42 | 2 | PF01825 | |
| Domain | EGF | 2.84e-03 | 126 | 42 | 3 | PF00008 | |
| Domain | GPS | 2.96e-03 | 36 | 42 | 2 | PS50221 | |
| Domain | GPS | 3.13e-03 | 37 | 42 | 2 | IPR000203 | |
| Domain | Znf_FYVE_PHD | 4.38e-03 | 147 | 42 | 3 | IPR011011 | |
| Domain | PSI | 4.40e-03 | 44 | 42 | 2 | IPR016201 | |
| Domain | PSI | 4.80e-03 | 46 | 42 | 2 | SM00423 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 5.65e-03 | 50 | 42 | 2 | PS00650 | |
| Domain | 7tm_2 | 5.65e-03 | 50 | 42 | 2 | PF00002 | |
| Domain | GPCR_2-like | 8.05e-03 | 60 | 42 | 2 | IPR017981 | |
| Domain | GPCR_2_secretin-like | 8.05e-03 | 60 | 42 | 2 | IPR000832 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 8.31e-03 | 61 | 42 | 2 | PS50261 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 2.54e-04 | 11 | 31 | 2 | M158 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 4.01e-04 | 66 | 31 | 3 | M18 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 6.07e-04 | 76 | 31 | 3 | M27219 | |
| Pathway | WP_FOCAL_ADHESION | 7.13e-04 | 187 | 31 | 4 | MM15913 | |
| Pathway | WP_ASPIRIN_AND_MIRNAS | 7.82e-04 | 19 | 31 | 2 | M48319 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 8.13e-04 | 84 | 31 | 3 | M7098 | |
| Pathway | WP_FOCAL_ADHESION | 8.99e-04 | 199 | 31 | 4 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 8.99e-04 | 199 | 31 | 4 | M7253 | |
| Pathway | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | 1.13e-03 | 94 | 31 | 3 | M797 | |
| Pathway | WP_GPCRS_CLASS_B_SECRETINLIKE | 1.25e-03 | 24 | 31 | 2 | M39643 | |
| Pathway | WP_GPCRS_CLASS_B_SECRETINLIKE | 1.25e-03 | 24 | 31 | 2 | MM15992 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 28056993 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 18326527 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 17158902 | ||
| Pubmed | Contradictory Role of CD97 in Basal and Tumor Necrosis Factor-Induced Osteoclastogenesis In Vivo. | 1.71e-06 | 2 | 46 | 2 | 26663852 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 26341082 | ||
| Pubmed | The role of the RGD motif in CD97/ADGRE5-and EMR2/ADGRE2-modulated tumor angiogenesis. | 1.71e-06 | 2 | 46 | 2 | 31594642 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 24949957 | ||
| Pubmed | The C-terminal region of laminin beta chains modulates the integrin binding affinities of laminins. | 1.71e-06 | 2 | 46 | 2 | 19147489 | |
| Pubmed | CD97 is differentially expressed on murine hematopoietic stem-and progenitor-cells. | 1.71e-06 | 2 | 46 | 2 | 18603564 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 18941248 | ||
| Pubmed | The mammalian Ced-1 ortholog MEGF10/KIAA1780 displays a novel adhesion pattern. | 1.71e-06 | 2 | 46 | 2 | 17498693 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 14707087 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 20084281 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 20167235 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 12829604 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 34314469 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 31969668 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 18267122 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 23676664 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 29599141 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 10744645 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 21876163 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 19197986 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 15498814 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 19717518 | ||
| Pubmed | 3.53e-06 | 175 | 46 | 5 | 28071719 | ||
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 10814726 | ||
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 29669286 | ||
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 10540231 | ||
| Pubmed | Deletion of either CD55 or CD97 ameliorates arthritis in mouse models. | 5.13e-06 | 3 | 46 | 2 | 20131275 | |
| Pubmed | The novel SPARC family member SMOC-2 potentiates angiogenic growth factor activity. | 5.13e-06 | 3 | 46 | 2 | 16774925 | |
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 23447688 | ||
| Pubmed | Sequencing of laminin B chain cDNAs reveals C-terminal regions of coiled-coil alpha-helix. | 5.13e-06 | 3 | 46 | 2 | 6209134 | |
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 34298973 | ||
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 11297558 | ||
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 33497605 | ||
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 17449467 | ||
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 11122379 | ||
| Pubmed | Laminins 411 and 421 differentially promote tumor cell migration via α6β1 integrin and MCAM (CD146). | 1.03e-05 | 4 | 46 | 2 | 24951930 | |
| Pubmed | Regulation and Function of Laminin A5 during Mouse and Human Decidualization. | 1.03e-05 | 4 | 46 | 2 | 35008625 | |
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 19721717 | ||
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 2099832 | ||
| Pubmed | Role of mesenchymal nidogen for epithelial morphogenesis in vitro. | 1.03e-05 | 4 | 46 | 2 | 7925005 | |
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 37978243 | ||
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 19339510 | ||
| Pubmed | Changes in laminin isoforms associated with brain tumor invasion and angiogenesis. | 1.03e-05 | 4 | 46 | 2 | 16146715 | |
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 8034675 | ||
| Pubmed | 1.71e-05 | 5 | 46 | 2 | 10964500 | ||
| Pubmed | 1.71e-05 | 5 | 46 | 2 | 24647208 | ||
| Pubmed | 1.71e-05 | 5 | 46 | 2 | 12743034 | ||
| Pubmed | 1.71e-05 | 5 | 46 | 2 | 15063179 | ||
| Pubmed | 1.84e-05 | 118 | 46 | 4 | 21078624 | ||
| Pubmed | 2.07e-05 | 40 | 46 | 3 | 27068110 | ||
| Pubmed | 2.56e-05 | 6 | 46 | 2 | 1678389 | ||
| Pubmed | Structural elucidation of full-length nidogen and the laminin-nidogen complex in solution. | 2.56e-05 | 6 | 46 | 2 | 23948589 | |
| Pubmed | 2.56e-05 | 6 | 46 | 2 | 2119632 | ||
| Pubmed | 2.56e-05 | 6 | 46 | 2 | 10501980 | ||
| Pubmed | A novel role for CD55 in granulocyte homeostasis and anti-bacterial host defense. | 2.56e-05 | 6 | 46 | 2 | 21984892 | |
| Pubmed | 2.56e-05 | 6 | 46 | 2 | 16041630 | ||
| Pubmed | 2.56e-05 | 6 | 46 | 2 | 14647991 | ||
| Pubmed | Laminin-10 and Lutheran blood group glycoproteins in adhesion of human endothelial cells. | 2.56e-05 | 6 | 46 | 2 | 16236823 | |
| Pubmed | 2.56e-05 | 6 | 46 | 2 | 26555376 | ||
| Pubmed | Effect of basement membrane entactin on epidermal cell attachment and growth. | 2.56e-05 | 6 | 46 | 2 | 3794389 | |
| Pubmed | 2.56e-05 | 6 | 46 | 2 | 20874775 | ||
| Pubmed | Laminin-nidogen complex. Extraction with chelating agents and structural characterization. | 2.56e-05 | 6 | 46 | 2 | 3109910 | |
| Pubmed | 2.56e-05 | 6 | 46 | 2 | 10671376 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 3.12e-05 | 135 | 46 | 4 | 28675934 | |
| Pubmed | Glial precursors clear sensory neuron corpses during development via Jedi-1, an engulfment receptor. | 3.58e-05 | 7 | 46 | 2 | 19915564 | |
| Pubmed | 3.58e-05 | 7 | 46 | 2 | 7921537 | ||
| Pubmed | 3.58e-05 | 7 | 46 | 2 | 11891225 | ||
| Pubmed | Laminins promote the locomotion of skeletal myoblasts via the alpha 7 integrin receptor. | 3.58e-05 | 7 | 46 | 2 | 9004048 | |
| Pubmed | 3.58e-05 | 7 | 46 | 2 | 14557481 | ||
| Pubmed | CD97 promotes spleen dendritic cell homeostasis through the mechanosensing of red blood cells. | 3.58e-05 | 7 | 46 | 2 | 35143305 | |
| Pubmed | 4.77e-05 | 8 | 46 | 2 | 24760005 | ||
| Pubmed | Linkage of genes for laminin B1 and B2 subunits on chromosome 1 in mouse. | 4.77e-05 | 8 | 46 | 2 | 2993224 | |
| Pubmed | Dynamic encounters with red blood cells trigger splenic marginal zone B cell retention and function. | 4.77e-05 | 8 | 46 | 2 | 38049580 | |
| Pubmed | 5.09e-05 | 153 | 46 | 4 | 25037231 | ||
| Pubmed | 6.12e-05 | 9 | 46 | 2 | 25892012 | ||
| Pubmed | 7.65e-05 | 10 | 46 | 2 | 9034910 | ||
| Pubmed | 8.53e-05 | 64 | 46 | 3 | 22261194 | ||
| Pubmed | Anuria, omphalocele, and perinatal lethality in mice lacking the CD34-related protein podocalyxin. | 9.34e-05 | 11 | 46 | 2 | 11435469 | |
| Pubmed | Regional differences in the expression of laminin isoforms during mouse neural tube development. | 9.34e-05 | 11 | 46 | 2 | 21524702 | |
| Pubmed | Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities. | 9.34e-05 | 11 | 46 | 2 | 23472759 | |
| Pubmed | 1.12e-04 | 12 | 46 | 2 | 26794322 | ||
| Pubmed | 1.12e-04 | 12 | 46 | 2 | 8918877 | ||
| Pubmed | 1.12e-04 | 12 | 46 | 2 | 9396756 | ||
| Pubmed | 1.32e-04 | 13 | 46 | 2 | 24572910 | ||
| Pubmed | 1.32e-04 | 13 | 46 | 2 | 12682087 | ||
| Pubmed | 1.32e-04 | 13 | 46 | 2 | 36350252 | ||
| Pubmed | 1.44e-04 | 608 | 46 | 6 | 16713569 | ||
| Pubmed | Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease. | 1.54e-04 | 78 | 46 | 3 | 19204726 | |
| Pubmed | 1.54e-04 | 14 | 46 | 2 | 28893945 | ||
| Pubmed | Complement factor H, a marker of self protects against experimental autoimmune encephalomyelitis. | 1.54e-04 | 14 | 46 | 2 | 19299737 | |
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 1.60e-04 | 79 | 46 | 3 | 18757743 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 1.60e-04 | 1201 | 46 | 8 | 35696571 | |
| Pubmed | 1.78e-04 | 15 | 46 | 2 | 21045126 | ||
| Pubmed | Basement membrane composition in the early mouse embryo day 7. | 1.78e-04 | 15 | 46 | 2 | 15895400 | |
| Pubmed | Semaphorin 4C and 4G are ligands of Plexin-B2 required in cerebellar development. | 1.78e-04 | 15 | 46 | 2 | 21122816 | |
| Pubmed | Laminin alpha5 chain is required for intestinal smooth muscle development. | 1.78e-04 | 15 | 46 | 2 | 12921739 | |
| Pubmed | 1.78e-04 | 15 | 46 | 2 | 31812516 | ||
| Cytoband | 1p36.3 | 8.87e-05 | 14 | 46 | 2 | 1p36.3 | |
| Cytoband | 14q11.2 | 7.95e-04 | 180 | 46 | 3 | 14q11.2 | |
| Cytoband | 6q27 | 1.41e-03 | 55 | 46 | 2 | 6q27 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q27 | 2.95e-03 | 80 | 46 | 2 | chr6q27 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr14q11 | 4.52e-03 | 332 | 46 | 3 | chr14q11 | |
| GeneFamily | CD molecules|Adhesion G protein-coupled receptors, subfamily E | 3.63e-05 | 5 | 35 | 2 | 915 | |
| GeneFamily | Laminin subunits | 2.37e-04 | 12 | 35 | 2 | 626 | |
| Coexpression | NABA_MATRISOME | LAMB1 LAMB2 ADAM33 EGFL7 SMOC2 MEGF6 TNXB WNT1 MEGF11 MEGF10 SEMA4G PLXNB1 VEGFA | 8.67e-09 | 1008 | 45 | 13 | MM17056 |
| Coexpression | NABA_MATRISOME | LAMB1 LAMB2 ADAM33 EGFL7 SMOC2 MEGF6 TNXB WNT1 MEGF11 MEGF10 SEMA4G PLXNB1 VEGFA | 1.07e-08 | 1026 | 45 | 13 | M5889 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 3.79e-06 | 738 | 45 | 9 | MM17058 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 4.36e-06 | 751 | 45 | 9 | M5885 | |
| Coexpression | NABA_SECRETED_FACTORS | 2.34e-05 | 338 | 45 | 6 | MM17064 | |
| Coexpression | GSE17721_POLYIC_VS_GARDIQUIMOD_1H_BMDC_UP | 2.35e-05 | 200 | 45 | 5 | M4016 | |
| Coexpression | NABA_SECRETED_FACTORS | 2.55e-05 | 343 | 45 | 6 | M5883 | |
| Coexpression | RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_DN | 8.02e-05 | 8 | 45 | 2 | M1337 | |
| Coexpression | RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_DN | 8.02e-05 | 8 | 45 | 2 | MM556 | |
| Coexpression | GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TREG_CD4_TCELL_DN | 9.53e-05 | 139 | 45 | 4 | M8948 | |
| Coexpression | SWEET_LUNG_CANCER_KRAS_DN | 1.06e-04 | 444 | 45 | 6 | MM1051 | |
| Coexpression | VERHAAK_GLIOBLASTOMA_CLASSICAL | 1.68e-04 | 161 | 45 | 4 | M2121 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP | 1.76e-04 | 163 | 45 | 4 | M12112 | |
| Coexpression | HASINA_NOL7_TARGETS_DN | 2.22e-04 | 13 | 45 | 2 | M596 | |
| Coexpression | GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_12H_ACT_CD4_TCELL_DN | 3.22e-04 | 191 | 45 | 4 | M4222 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 3.22e-04 | 191 | 45 | 4 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 3.55e-04 | 196 | 45 | 4 | M3008 | |
| Coexpression | GSE3982_NEUTROPHIL_VS_NKCELL_UP | 3.76e-04 | 199 | 45 | 4 | M5530 | |
| Coexpression | GSE17721_POLYIC_VS_CPG_0.5H_BMDC_UP | 3.76e-04 | 199 | 45 | 4 | M3932 | |
| Coexpression | GSE21379_TFH_VS_NON_TFH_SAP_KO_CD4_TCELL_DN | 3.76e-04 | 199 | 45 | 4 | M7510 | |
| Coexpression | GSE9316_IL6_KO_VS_IFNG_KO_INVIVO_EXPANDED_CD4_TCELL_UP | 3.84e-04 | 200 | 45 | 4 | M6888 | |
| Coexpression | GSE13493_DP_VS_CD4INTCD8POS_THYMOCYTE_UP | 3.84e-04 | 200 | 45 | 4 | M3312 | |
| Coexpression | GSE27786_CD8_TCELL_VS_NKTCELL_DN | 3.84e-04 | 200 | 45 | 4 | M4840 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.57e-07 | 173 | 46 | 5 | 30d67738633493d47f06ae452424382f069b6c0a | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.85e-07 | 174 | 46 | 5 | a9c6edf5c3fc119c24425f921c5566a8356c30fe | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.30e-06 | 184 | 46 | 5 | 2b7e6f91e11c228f0521e099886867d9e998e78d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-06 | 188 | 46 | 5 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 1.44e-06 | 188 | 46 | 5 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-06 | 190 | 46 | 5 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-06 | 191 | 46 | 5 | 2c51850f5c559d665b8a27a12b75af9ed58dffe1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-06 | 193 | 46 | 5 | 09a9ab029f01234459a88e3e994fe90ef4cbb8c6 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.86e-06 | 198 | 46 | 5 | 8f25e8dff42bad8e779ca618bdb1cb1610667962 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.86e-06 | 198 | 46 | 5 | e3e0aa3ef20b2370f5b133048510677aaa562dfa | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-05 | 169 | 46 | 4 | 849a8f8509c58d65462a09c84d58b6ecdc8934f5 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.25e-05 | 176 | 46 | 4 | 8e7f38de8bf68077e2138f4d06c1f55b0fd096cc | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.25e-05 | 176 | 46 | 4 | ed575330a08a6748ea4b28433292c8cfd157d444 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-05 | 176 | 46 | 4 | fee4e0f32aaf77294040c7af6c1f503571750d43 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-05 | 176 | 46 | 4 | f25251abd4ef9fb077a978f9f9f658af58e4e0d2 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.70e-05 | 182 | 46 | 4 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.78e-05 | 183 | 46 | 4 | 06a68fa2be36448064f4668be24a5b85ad85c6e8 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.86e-05 | 184 | 46 | 4 | 607b55022de21ddb6a2d75e085df76df7abf6624 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.95e-05 | 185 | 46 | 4 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | Control-Epithelial-Mesothelial|Epithelial / Disease state, Lineage and Cell class | 3.95e-05 | 185 | 46 | 4 | 0af540323c0113203ba6c1a4cb32d2fb9cf79d39 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.03e-05 | 186 | 46 | 4 | 7582b5154d8e5a4434817b5ab77a10b789ea2288 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.20e-05 | 188 | 46 | 4 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.20e-05 | 188 | 46 | 4 | 7191087d8754f5e8700e3d744cd920ee26db1e57 | |
| ToppCell | droplet-Fat-SCAT-30m|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-05 | 189 | 46 | 4 | 8161910a19089f8cc5a3f1fda039f41a2488f04f | |
| ToppCell | droplet-Fat-SCAT|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-05 | 189 | 46 | 4 | 264c59de2adb8bee5bb57633d79d530a8829617b | |
| ToppCell | facs-SCAT-Fat-24m-Mesenchymal-mesenchymal_progenitor|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.38e-05 | 190 | 46 | 4 | dc7e92f1b18d0f5efec11d09d56ba954d4f8b3bd | |
| ToppCell | facs-SCAT-Fat-24m-Mesenchymal-mesenchymal_stem_cell_of_adipose|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.38e-05 | 190 | 46 | 4 | 0bb06df3d5a50416854370f234718c6cec3d773b | |
| ToppCell | facs-SCAT-Fat-24m-Mesenchymal|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.38e-05 | 190 | 46 | 4 | 008290bb5c79446681dd6bf354336c57ad0d6f13 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.38e-05 | 190 | 46 | 4 | 7df63e5e0dd395676f4fc18cad0d8b2428390943 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.38e-05 | 190 | 46 | 4 | 140aca04c044cd7a93f81ff1631b00b5216d2cb1 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell-Mesothelium-Mesothelium_L.2.6.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.47e-05 | 191 | 46 | 4 | b7713aba839e7a1f548b7b9d8893067bcc6d7ee7 | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.47e-05 | 191 | 46 | 4 | 6cab0334f76c973880bd8d1638856f2f6e4a249a | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.47e-05 | 191 | 46 | 4 | 850c6fff6dc795431ef534fdaa41e4ad50f7367a | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.47e-05 | 191 | 46 | 4 | 8b2b00202d3c98bccbae1b4a23713892fad0ff23 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.47e-05 | 191 | 46 | 4 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 4.47e-05 | 191 | 46 | 4 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.56e-05 | 192 | 46 | 4 | 4ed5040594ba2d0639f0990697504ecef872ca70 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-05 | 192 | 46 | 4 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.56e-05 | 192 | 46 | 4 | d4f5d6653564c2c5d0f5f7c932d89cb1b1412844 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-05 | 192 | 46 | 4 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.56e-05 | 192 | 46 | 4 | b9e4585bea280ca0ae159f0c6a2bf7b88a15a6e6 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-05 | 192 | 46 | 4 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell|Adult / Lineage, Cell type, age group and donor | 4.56e-05 | 192 | 46 | 4 | d21f0f577156f17c899b08871046a26b88aea011 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.65e-05 | 193 | 46 | 4 | 9d0b966d13cbce97beb43de6dc77f006c363a181 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.65e-05 | 193 | 46 | 4 | 2483bb7f398e4fa0ef09c8bd584ed25703853f03 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.65e-05 | 193 | 46 | 4 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.75e-05 | 194 | 46 | 4 | c49f72441b3557e2c3a9c4239e68c0cf0652814b | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.84e-05 | 195 | 46 | 4 | 69a29d03e664b72f32d41876510c62345c3aed31 | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.84e-05 | 195 | 46 | 4 | d32716a12014522492becbde1088dc1106308490 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 4.84e-05 | 195 | 46 | 4 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.84e-05 | 195 | 46 | 4 | 1cffae2b08dbfa1c633ce24023e89b66d28b5431 | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.84e-05 | 195 | 46 | 4 | b913d5df50c88a3a255f516a1aa42419c6701e1e | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.84e-05 | 195 | 46 | 4 | 9cef6f18664518060af7c192310dddce6d70345a | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.94e-05 | 196 | 46 | 4 | 379132e944be2b9dcdf1a787293a48313956902c | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.04e-05 | 197 | 46 | 4 | f0475ad9c09c6da418dba17d3d3c1aaa2ef9ab4e | |
| ToppCell | distal-mesenchymal-Lipofibroblast-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.04e-05 | 197 | 46 | 4 | 865010edcd7e3f79f505fcef7b33882095994aa8 | |
| ToppCell | distal-mesenchymal-Lipofibroblast|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.04e-05 | 197 | 46 | 4 | ceb83bdef16b58ee16193413bfb006f7715728b2 | |
| ToppCell | 5'-Adult-Distal_Rectal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.14e-05 | 198 | 46 | 4 | db26c20321f9ab102d6484f22ddb2bde684067b1 | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Fibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | 5.34e-05 | 200 | 46 | 4 | 9996b6887cf2b1936e10a1aa396f09fd8da5f4c4 | |
| ToppCell | Bronchial-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.34e-05 | 200 | 46 | 4 | 5ea12e17f50fefbf5534e487af3392b2fa2d13ad | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.34e-05 | 200 | 46 | 4 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_adventitial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.34e-05 | 200 | 46 | 4 | fc3c4778841c4b8bac0afb458352614b2c460617 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Peri/Epineurial_|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.34e-05 | 200 | 46 | 4 | 5ad3ea1cf1fcd4100966c5517bc7ed0a1af54317 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_adventitial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.34e-05 | 200 | 46 | 4 | b04831708fa20471a127b87e8db3728b6e729ce8 | |
| ToppCell | Biopsy_IPF-Mesenchymal|Biopsy_IPF / Sample group, Lineage and Cell type | 5.34e-05 | 200 | 46 | 4 | bb605b373caf3f873dc1b87d712704568e0d6040 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 5.34e-05 | 200 | 46 | 4 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.78e-04 | 123 | 46 | 3 | 87401764a073c1808f214642a9c84299c78f7ec7 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.91e-04 | 125 | 46 | 3 | b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b | |
| ToppCell | Control-Epithelial_alveolar-Mes-Like-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.05e-04 | 127 | 46 | 3 | 556aaf88719c83f307fa50dfac151136ed05c8ad | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_immature|E16.5-samps / Age Group, Lineage, Cell class and subclass | 3.19e-04 | 129 | 46 | 3 | 5e4783cc63afdeaebdfaecb72f95f3efc8d3c4a3 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 5.56e-04 | 156 | 46 | 3 | 10d191e29b16cae8238e8df6c0ff38882253f34e | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.77e-04 | 158 | 46 | 3 | ba9998cbf786c515d30fe42de02c7a246db1b6f9 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.77e-04 | 158 | 46 | 3 | a2efcc184ef13d81373e3690253ba35f6be09c5f | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Papillary_Muscle_Invasive_Urothelial_Carcinoma|TCGA-Bladder / Sample_Type by Project: Shred V9 | 5.77e-04 | 158 | 46 | 3 | dc559503bab3ec1b9ea54ef2e896d1be33e5344c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.77e-04 | 158 | 46 | 3 | e52eff2bd1e7e0ce9c278ed5109802865e0fe69c | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.88e-04 | 159 | 46 | 3 | fb9a45c1d596226128ce4f1adaebb066766e590a | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_B-B_lineage-pro_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.99e-04 | 160 | 46 | 3 | 30b7f24e0c3ecfa618b4e31678e18c8a4405a8d7 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.99e-04 | 160 | 46 | 3 | 6ed37d1fd0304932319d6b942502404115ff36a7 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.21e-04 | 162 | 46 | 3 | ca30d9bf61f4133566fdc91c7996e130ea554d01 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-4_VIP_DSEL|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.43e-04 | 164 | 46 | 3 | 4baba91f9f734976aef9db2822ff8683b26ea155 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-4_VIP_DSEL|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.43e-04 | 164 | 46 | 3 | dd60edc48a6089148016c4d02f6826f04b747b78 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-4_VIP_DSEL|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.43e-04 | 164 | 46 | 3 | 4a4c32d242db97216cb345e59865c2c826c8b9f2 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.55e-04 | 165 | 46 | 3 | 4e13fccd32029e2879e85f8966e582a46c09e4aa | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-04 | 165 | 46 | 3 | f80665b75d43f1bf6919d59fc762e7e0bac653f2 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.66e-04 | 166 | 46 | 3 | 9d4b44eb56ad38c26aed73444edf389abca6bdf6 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-04 | 167 | 46 | 3 | 3e3d8f6df2feefafad5b44ba0ebf5b5a0fe4ed58 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-04 | 167 | 46 | 3 | 3ad9f3122dbe96580f640388ef920ea209fc2349 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-04 | 167 | 46 | 3 | a35ace2c722936d2a3e1f0826e5b6ec6b1340d2b | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.90e-04 | 168 | 46 | 3 | 260c768468dff51888f7a68e5424bb174dbaa759 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.90e-04 | 168 | 46 | 3 | 18d7719a76620d5e5698f9ffd08b4ad4cb7c13f8 | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.90e-04 | 168 | 46 | 3 | b08458164d270d625b8ee390122d1c2ce8c653db | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.90e-04 | 168 | 46 | 3 | 4b2d29a7843bf45922038c093ca7ec0600756adc | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.02e-04 | 169 | 46 | 3 | 5f5bec13208f4c3b6eacbba180c8a6402743b76e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.14e-04 | 170 | 46 | 3 | 09bcbc7eb3b1d35cf03f01ce2f2fe37373382dd4 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-4_VIP_DSEL|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.26e-04 | 171 | 46 | 3 | 2c7d73f1386ddd172839734c68ed3859a90f80f8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.26e-04 | 171 | 46 | 3 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Monocytic|GI_small-bowel / Manually curated celltypes from each tissue | 7.26e-04 | 171 | 46 | 3 | 098a7fd387357c0d4e1a6169af4d24ef95b30018 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.51e-04 | 173 | 46 | 3 | bba8265a58f8f5659dc7b9da2fe27b15033fce34 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.51e-04 | 173 | 46 | 3 | ee7d1429f23f1b89a9a9f7bc07a84a44cf7acd1c | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.51e-04 | 173 | 46 | 3 | 3725525b99a6011eda2ff5459b4fd2e1eab1f090 | |
| Disease | proteinuria (implicated_via_orthology) | 1.22e-05 | 30 | 44 | 3 | DOID:576 (implicated_via_orthology) | |
| Disease | adhesion G protein-coupled receptor E2 measurement | 1.30e-05 | 4 | 44 | 2 | EFO_0021892 | |
| Disease | interleukin-36 alpha measurement | 7.77e-05 | 9 | 44 | 2 | EFO_0021851 | |
| Disease | Complications of Diabetes Mellitus | 1.19e-04 | 11 | 44 | 2 | C0342257 | |
| Disease | squamous cell carcinoma | 1.39e-04 | 67 | 44 | 3 | EFO_0000707 | |
| Disease | basal cell carcinoma | 1.81e-04 | 189 | 44 | 4 | EFO_0004193 | |
| Disease | caffeine measurement | 2.25e-04 | 15 | 44 | 2 | EFO_0021177 | |
| Disease | endoplasmic reticulum resident protein 29 measurement | 2.57e-04 | 16 | 44 | 2 | EFO_0020346 | |
| Disease | tonsillectomy risk measurement | 6.06e-04 | 260 | 44 | 4 | EFO_0007924 | |
| Disease | visuospatial function measurement | 6.90e-04 | 26 | 44 | 2 | EFO_0803533 | |
| Disease | keratinocyte carcinoma | 7.33e-04 | 118 | 44 | 3 | EFO_0010176 | |
| Disease | docosapentaenoic acid measurement | 7.45e-04 | 27 | 44 | 2 | EFO_0006809 | |
| Disease | platelet component distribution width | 8.48e-04 | 755 | 44 | 6 | EFO_0007984 | |
| Disease | adiponectin measurement | 1.35e-03 | 146 | 44 | 3 | EFO_0004502 | |
| Disease | Cognition Disorders | 1.48e-03 | 38 | 44 | 2 | C0009241 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YACCPGWKRTSGLPG | 86 | Q9UHF1 | |
| YSCRCRPGWKPRHGI | 236 | Q9UHX3 | |
| GSYSCRCRPGWKPRH | 231 | P48960 | |
| LLDGSPCARGSGYCW | 501 | Q9BZ11 | |
| PGAGLAWCCYRLPGA | 716 | Q9BZ11 | |
| YGPGVGRIWLDNVRC | 301 | O43866 | |
| CGVRGEQWRIGLCYL | 181 | A6NFU0 | |
| CRLPWGAEREYGGII | 56 | Q8N865 | |
| FGGLLCVCWSPDGRY | 326 | Q09019 | |
| YVLCVAWRDRLPAGG | 671 | Q8IZY2 | |
| LWGPHRYGCLAGVRV | 136 | Q9P258 | |
| GCRGCLLAPRWTGLA | 151 | A0A5F9ZHS7 | |
| GWTGLYCTQRCPLGF | 736 | Q96KG7 | |
| GFRGWRCEELCAPGT | 166 | A6BM72 | |
| AYCPGLGRWLCLGTL | 486 | A6NCF5 | |
| GYCLPWDRPCGLGSG | 306 | Q7Z4F1 | |
| RCLCWPGYSGELCEV | 246 | Q5IJ48 | |
| TVAGYICRCPETWGG | 376 | Q5IJ48 | |
| RSCGFWPGYLILCLE | 981 | Q9UPZ3 | |
| DPYCGWCVLLGRCSR | 496 | O43157 | |
| VYARQCDRCLPGHWG | 846 | P07942 | |
| LVTGRGCDRCLPGHW | 496 | P55268 | |
| GIYRCCYRRPDWGPG | 96 | Q8IYS5 | |
| FCVGLGAIPSGRWIC | 461 | Q8WUB8 | |
| PSCLTWLGLGIACYR | 1031 | Q5T0N1 | |
| PDGWIRRCYYGTGRC | 31 | Q30KQ5 | |
| CIRWSYGAGIVLRLG | 421 | Q9Y512 | |
| LIYERGVEVGCWGLC | 361 | Q9UMX9 | |
| CRSVGPYVPLWLGCE | 336 | Q96FA3 | |
| GFLLARIAGLPWYRC | 241 | Q12908 | |
| GADGDWLVPLGRCIC | 251 | Q9UF33 | |
| WTGRHCELACPPGRY | 1326 | O75095 | |
| ARHYGECLCWPLLPG | 101 | A1L4L8 | |
| RYGSWLGAISCPICR | 116 | Q96K19 | |
| CTGGSRLYLWSPAGC | 391 | Q9P2S5 | |
| DWDSQGLYLCLRGCP | 306 | Q96B86 | |
| GVPYIPEGQWLCRRC | 306 | P55201 | |
| GGPGPRYELRDCCWV | 46 | Q5GH72 | |
| DCILARDPYCGWDPG | 516 | Q9NTN9 | |
| RQKGITCRRYPCEWG | 1066 | Q99973 | |
| TCRRYPCEWGGVAAG | 1071 | Q99973 | |
| GYCWCVLVDTGRPIP | 256 | Q9H3U7 | |
| RCVDGRCVCWPGYTG | 351 | P22105 | |
| RGRCEDGRCVCWPGY | 411 | P22105 | |
| CLWPRSGICGREYGL | 651 | Q9H1D0 | |
| RGWGPAPVRVCDNCY | 641 | Q9HBF4 | |
| CTCDYRRRGPGGPDW | 151 | P04628 | |
| RGSIGVWHYICPRLG | 126 | Q9H1V8 | |
| YVGARCCLMPWSLPG | 166 | P15692 | |
| ICVGFLGPRWARGCS | 86 | Q6PDA7 | |
| RLGPELEICGYGCWD | 41 | Q6IA69 |